Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer

NCT00631410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: sunitinib + mFOLFOX6
DRUG: sunitinib + mFOLFOX6

Sponsor

Pfizer